Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06933758 · ClinicalTrials.gov registry record
Temple Health Chest Initiative (THCI 2.0)
A clinical trial of Chronic Obstructive Pulmonary Disease (COPD), sponsored by Temple University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06933758 is a study of Chronic Obstructive Pulmonary Disease (COPD) that is actively recruiting participants, run by Temple University. The registered enrollment target is 1,000 participants, above the 623-participant average among 36 other Chronic Obstructive Pulmonary Disease (COPD) trials with a reported enrollment target (61% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06933758, a study of Chronic Obstructive Pulmonary Disease (COPD), is actively recruiting participants, sponsored by Temple University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT screening for lung cancer in patients aged 50- 80 with ≥ 20 pack year smoking has been shown to improve survival. COPD is highly prevalent within LCS programs, with estimated rates of obstructive lung function of up to 59% and evidence of emphysema on CT scan in around 70%.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Determine COPD prevalence utilizing spirometry along with CT scans and symptom assessments in the THCI lung cancer screening populatio
Study Locations (1)
Pennsylvania
- Temple University Of the Commonwealth System of Higher Education - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-02-28 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06933758
The ClinicalTrials.gov registry entry for NCT06933758 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 623-participant average among 36 other Chronic Obstructive Pulmonary Disease (COPD) trials with a reported enrollment target (61% higher). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Obstructive Pulmonary Disease (COPD) appearing as the primary indexed condition, and to 1 intervention - of which Determine COPD prevalence utilizing spirometry along with CT scans and symptom assessments in the THCI lung cancer screening populatio is the first listed.
NCT06933758 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06933758 about?
NCT06933758 is a clinical study titled "Temple Health Chest Initiative (THCI 2.0)". Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for ...
What is the current status of trial NCT06933758?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-02-28. Estimated completion is 2026-06-30.
What conditions does trial NCT06933758 study?
This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease (COPD).
What interventions are being tested in trial NCT06933758?
The interventions under investigation include: Determine COPD prevalence utilizing spirometry along with CT scans and symptom assessments in the THCI lung cancer screening populatio (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06933758?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06933758 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Obstructive Pulmonary Disease (COPD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
-
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RECRUITING · Phase 2
-
Multi-Center Clean Air Randomized Controlled Trial in COPD
RECRUITING · Phase 3
-
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 3
-
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RECRUITING · Phase 3
-
Effectiveness of the WearME System for COPD Severity and Respiratory Function
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.